{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:46Z","timestamp":1791862246138,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"DOI":"10.1007\/s10072-023-07076-1","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:34:55Z","timestamp":1695857695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer\u2019s disease: racial differences"],"prefix":"10.1007","author":[{"given":"Chun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Miguel","family":"Saveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Osvaldo","family":"Navia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Adjeroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Alzheimer and Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"7076_CR1","doi-asserted-by":"crossref","unstructured":"Association A. s (2021) Alzheimer\u2019s disease facts and figures 2021. Alzheimer\u2019s Dement 17:327\u2013406","DOI":"10.1002\/alz.12328"},{"key":"7076_CR2","doi-asserted-by":"publisher","unstructured":"Association A. s (2016) 2016 Alzheimer's disease facts and figures. Alzheimers Dement 12:459\u2013509. https:\/\/doi.org\/10.1016\/j.jalz.2016.03.001. https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/abs\/ https:\/\/doi.org\/10.1016\/j.jalz.2016.03.001","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"7076_CR3","doi-asserted-by":"publisher","unstructured":"Association A. s (2022) 2022 Alzheimer's disease facts and figures. Alzheimers Dement 18:700\u201389. https:\/\/doi.org\/10.1002\/alz.12638. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35289055","DOI":"10.1002\/alz.12638"},{"key":"7076_CR4","doi-asserted-by":"publisher","unstructured":"Lozano S, Padilla V, Avila ML, Gil M, Maestre G, Wang K, Xu C (2021) APOE gene associated with cholesterol-related traits in the Hispanic population. Genes (Basel) 12. https:\/\/doi.org\/10.3390\/genes12111768. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34828374","DOI":"10.3390\/genes12111768"},{"key":"7076_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.biopsych.2013.06.003.10.1016\/j.biopsych.2013.06.003","volume":"75","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Genetics of Alzheimer\u2019s disease in Caribbean Hispanic and African American populations. Biol Psychiat 75:534\u2013541. https:\/\/doi.org\/10.1016\/j.biopsych.2013.06.003.10.1016\/j.biopsych.2013.06.003","journal-title":"Biol Psychiat"},{"key":"7076_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-981-32-9358-8_15","volume":"1184","author":"E Rodriguez-Vieitez","year":"2019","unstructured":"Rodriguez-Vieitez E, Nielsen HM (2019) Associations between APOE variants, tau and \u03b1-synuclein. Adv Exp Med Biol 1184:177\u2013186. https:\/\/doi.org\/10.1007\/978-981-32-9358-8_15","journal-title":"Adv Exp Med Biol"},{"key":"7076_CR7","doi-asserted-by":"publisher","unstructured":"Pang C, Yang H, Hu B, Wang S, Chen M, Cohen DS, Chen HS, Jarrell JT, Carpenter KA, Rosin ER et al (2019) Identification and analysis of Alzheimer's candidate genes by an amplitude deviation algorithm. J Alzheimers Dis Parkinsonism 9. https:\/\/doi.org\/10.4172\/2161-0460.1000460","DOI":"10.4172\/2161-0460.1000460"},{"key":"7076_CR8","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/wnl.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the united states (2010-2050) estimated using the 2010 census. Neurology 80:1778\u20131783. https:\/\/doi.org\/10.1212\/wnl.0b013e31828726f5","journal-title":"Neurology"},{"key":"7076_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008.10.1016\/j.jalz.2018.04.008","volume":"14","author":"RA Nebel","year":"2018","unstructured":"Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH et al (2018) Understanding the impact of sex and gender in Alzheimer\u2019s disease: a call to action. Alzheimers Dement 14:1171\u20131183. https:\/\/doi.org\/10.1016\/j.jalz.2018.04.008.10.1016\/j.jalz.2018.04.008","journal-title":"Alzheimers Dement"},{"key":"7076_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7.10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G (2019) Apolipoprotein e and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15:501\u2013518. https:\/\/doi.org\/10.1038\/s41582-019-0228-7.10.1038\/s41582-019-0228-7","journal-title":"Nat Rev Neurol"},{"key":"7076_CR11","doi-asserted-by":"publisher","unstructured":"Burnham SC, Laws SM, Budgeon CA, Dore V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA et al (2020) \"Impact of APOE-epsilon4 carriage on the onset and rates of neocortical Abeta-amyloid deposition. Neurobiol Aging 95:46\u201355. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.06.001. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32750666","DOI":"10.1016\/j.neurobiolaging.2020.06.001"},{"key":"7076_CR12","doi-asserted-by":"publisher","unstructured":"Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM et al (2022) The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci 23:53\u201366. https:\/\/doi.org\/10.1038\/s41583-021-00533-w. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34815562","DOI":"10.1038\/s41583-021-00533-w"},{"key":"7076_CR13","doi-asserted-by":"publisher","first-page":"e1003289","DOI":"10.1371\/journal.pmed.1003289","volume":"17","author":"H Saddiki","year":"2020","unstructured":"Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D, Alexopoulos P, Blennow K, Zetterberg H, Parnetti L et al (2020) Age and the association between apolipoprotein e genotype and Alzheimer disease: a cerebrospinal fluid biomarker\u2013based case\u2013control study. PLOS Med 17:e1003289. https:\/\/doi.org\/10.1371\/journal.pmed.1003289","journal-title":"PLOS Med"},{"key":"7076_CR14","doi-asserted-by":"publisher","unstructured":"Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B et al (2022) Effect of race on prediction of brain amyloidosis by plasma abeta42\/abeta40, phosphorylated tau, and neurofilament light. Neurology 99:e245-e57. https:\/\/doi.org\/10.1212\/WNL.0000000000200358. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35450967","DOI":"10.1212\/WNL.0000000000200358"},{"key":"7076_CR15","doi-asserted-by":"publisher","unstructured":"Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X (2022) Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention. Ageing Res Rev 74:101544. https:\/\/doi.org\/10.1016\/j.arr.2021.101544. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34933129","DOI":"10.1016\/j.arr.2021.101544"},{"key":"7076_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fnagi.2014.00287","volume":"6","author":"D Ferreira","year":"2014","unstructured":"Ferreira D, Rivero-Santana A, Perestelo-P\u00e9rez L, Westman E, Wahlund LO, Sarr\u00eda A, Serrano-Aguilar P (2014) Improving CSF biomarkers\u2019 performance for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease by considering different confounding factors: a meta-analysis. Front Aging Neurosci 6:287. https:\/\/doi.org\/10.3389\/fnagi.2014.00287","journal-title":"Front Aging Neurosci"},{"key":"7076_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/s1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D et al (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9:1118\u20131127. https:\/\/doi.org\/10.1016\/s1474-4422(10)70223-4","journal-title":"Lancet Neurol"},{"key":"7076_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","volume":"4","author":"TF Gendron","year":"2009","unstructured":"Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4:13. https:\/\/doi.org\/10.1186\/1750-1326-4-13","journal-title":"Mol Neurodegener"},{"key":"7076_CR19","doi-asserted-by":"publisher","unstructured":"Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Yaqub M, Mulder SD, Nivard MG, Vanderstichele H, Lammertsma AA, Teunissen CE et al (2021) Onset of preclinical Alzheimer disease in monozygotic twins. Ann Neurol 89:987\u20131000. https:\/\/doi.org\/10.1002\/ana.26048. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33583080","DOI":"10.1002\/ana.26048"},{"key":"7076_CR20","doi-asserted-by":"publisher","unstructured":"Jellinger KA (2020) Pathobiological subtypes of Alzheimer disease. Dement Geriatr Cogn Disord 49:321\u201333. https:\/\/doi.org\/10.1159\/000508625","DOI":"10.1159\/000508625"},{"key":"7076_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0304-3940(99)00617-5","volume":"273","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K (1999) Cerebrospinal fluid tau and abeta42 as predictors of development of Alzheimer\u2019s disease in patients with mild cognitive impairment. Neurosci Lett 273:5\u20138. https:\/\/doi.org\/10.1016\/s0304-3940(99)00617-5","journal-title":"Neurosci Lett"},{"key":"7076_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816.10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284:643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816.10.1111\/joim.12816","journal-title":"J Intern Med"},{"key":"7076_CR23","doi-asserted-by":"publisher","unstructured":"Husain MA, Laurent B, Plourde M (2021) APOE and Alzheimer's disease: from lipid transport to physiopathology and therapeutics. Front Neurosci 15:630502. https:\/\/doi.org\/10.3389\/fnins.2021.630502. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33679311","DOI":"10.3389\/fnins.2021.630502"},{"key":"7076_CR24","first-page":"689","volume":"24","author":"JR Cockrell","year":"1988","unstructured":"Cockrell JR, Folstein MF (1988) Mini-mental state examination (MMSE). Psychopharmacol Bull 24:689\u2013692","journal-title":"Psychopharmacol Bull"},{"key":"7076_CR25","doi-asserted-by":"publisher","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u201391. https:\/\/doi.org\/10.3758\/bf03193146. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17695343","DOI":"10.3758\/bf03193146"},{"key":"7076_CR26","doi-asserted-by":"publisher","unstructured":"Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149\u201360. https:\/\/doi.org\/10.3758\/BRM.41.4.1149. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19897823","DOI":"10.3758\/BRM.41.4.1149"},{"key":"7076_CR27","doi-asserted-by":"publisher","unstructured":"Gu L, Shu H, Wang Y, Wang P (2023) Blood neurofilament light chain in different types of dementia. Curr Alzheimer Res. https:\/\/doi.org\/10.2174\/1567205020666230601123123. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37264656","DOI":"10.2174\/1567205020666230601123123"},{"key":"7076_CR28","doi-asserted-by":"publisher","unstructured":"Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Palsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B et al (2014) Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiatry 71:1183\u201391. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1060. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25162367","DOI":"10.1001\/jamapsychiatry.2014.1060"},{"key":"7076_CR29","doi-asserted-by":"publisher","unstructured":"Konijnenberg E, Tijms BM, Gobom J, Dobricic V, Bos I, Vos S, Tsolaki M, Verhey F, Popp J, Martinez-Lage P et al (2020) APOE epsilon4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease. Alzheimers Res Ther 12:65. https:\/\/doi.org\/10.1186\/s13195-020-00628-z. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32460813","DOI":"10.1186\/s13195-020-00628-z"},{"key":"7076_CR30","doi-asserted-by":"publisher","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u201331. https:\/\/doi.org\/10.1002\/ana.21843. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20186853","DOI":"10.1002\/ana.21843"},{"key":"7076_CR31","doi-asserted-by":"publisher","unstructured":"Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR Jr, Aisen PS, Koeppe RA et al (2013) The role of apolipoprotein e (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci 5:11. https:\/\/doi.org\/10.3389\/fnagi.2013.00011. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23554593","DOI":"10.3389\/fnagi.2013.00011"},{"key":"7076_CR32","doi-asserted-by":"publisher","unstructured":"Benson GS, Bauer C, Hausner L, Couturier S, Lewczuk P, Peters O, Hull M, Jahn H, Jessen F, Pantel J et al (2022) Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the dementia competence network. J Neural Transm (Vienna) 129:477\u201386. https:\/\/doi.org\/10.1007\/s00702-022-02461-0. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35061102","DOI":"10.1007\/s00702-022-02461-0"},{"key":"7076_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AMH, Franklin RJM, Johnson T, Estrada K et al (2021) Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet 53:392\u2013402. https:\/\/doi.org\/10.1038\/s41588-020-00776-w","journal-title":"Nat Genet"},{"key":"7076_CR34","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","volume":"37","author":"S Suri","year":"2013","unstructured":"Suri S, Heise V, Trachtenberg AJ, Mackay CE (2013) The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE \u025b2. Neurosci Biobehav Rev 37:2878\u20132886. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.10.010","journal-title":"Neurosci Biobehav Rev"},{"key":"7076_CR35","doi-asserted-by":"publisher","unstructured":"Oikonomidi A, Tautvydaite D, Gholamrezaee MM, Henry H, Bacher M, Popp J (2017) Macrophage migration inhibitory factor is associated with biomarkers of Alzheimer's disease pathology and predicts cognitive decline in mild cognitive impairment and mild dementia. J Alzheimers Dis 60:273\u201381. https:\/\/doi.org\/10.3233\/JAD-170335. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28826184","DOI":"10.3233\/JAD-170335"},{"key":"7076_CR36","doi-asserted-by":"publisher","unstructured":"Grewal R, Haghighi M, Huang S, Smith AG, Cao C, Lin X, Lee DC, Teten N, Hill AM, Selenica MB (2016) Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients. Alzheimers Res Ther 8:43. https:\/\/doi.org\/10.1186\/s13195-016-0211-0. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27756387","DOI":"10.1186\/s13195-016-0211-0"},{"key":"7076_CR37","doi-asserted-by":"publisher","unstructured":"Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM et al (2019) Assessment of racial disparities in biomarkers for Alzheimer disease. JAMA Neurol 76:264\u201373. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4249. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30615028","DOI":"10.1001\/jamaneurol.2018.4249"},{"key":"7076_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-020-00767-3.10.1186\/s13195-020-00767-3","volume":"13","author":"S Moon","year":"2021","unstructured":"Moon S, Kim S, Mankhong S, Choi SH, Vandijck M, Kostanjevecki V, Jeong JH, Yoon SJ, Park KW, Kim E-J et al (2021) Alzheimer\u2019s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta pet and manual immunoassay in Koreans. Alzheimers Res Ther 13:22. https:\/\/doi.org\/10.1186\/s13195-020-00767-3.10.1186\/s13195-020-00767-3","journal-title":"Alzheimers Res Ther"},{"key":"7076_CR39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1076\/jcen.25.5.680.14579","volume":"25","author":"JJ Manly","year":"2003","unstructured":"Manly JJ, Touradji P, Tang MX, Stern Y (2003) Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol 25:680\u2013690. https:\/\/doi.org\/10.1076\/jcen.25.5.680.14579","journal-title":"J Clin Exp Neuropsychol"},{"key":"7076_CR40","doi-asserted-by":"publisher","first-page":"f7051","DOI":"10.1136\/bmj.f7051","volume":"347","author":"K Yaffe","year":"2013","unstructured":"Yaffe K, Falvey C, Harris TB, Newman A, Satterfield S, Koster A, Ayonayon H, Simonsick E (2013) Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. Bmj 347:f7051. https:\/\/doi.org\/10.1136\/bmj.f7051","journal-title":"Bmj"},{"key":"7076_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","volume":"33","author":"LL Barnes","year":"2014","unstructured":"Barnes LL, Bennett DA (2014) Alzheimer\u2019s disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood) 33:580\u2013586. https:\/\/doi.org\/10.1377\/hlthaff.2013.1353","journal-title":"Health Aff (Millwood)"},{"key":"7076_CR42","doi-asserted-by":"publisher","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V et al (2022) New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet 54:412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35379992","DOI":"10.1038\/s41588-022-01024-z"},{"key":"7076_CR43","doi-asserted-by":"publisher","unstructured":"Misiura MB, Howell JC, Wu J, Qiu D, Parker MW, Turner JA, Hu WT (2020) Race modifies default mode connectivity in Alzheimer's disease. Transl Neurodegener 9:8. https:\/\/doi.org\/10.1186\/s40035-020-0186-4. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32099645","DOI":"10.1186\/s40035-020-0186-4"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07076-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:35:49Z","timestamp":1695857749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07076-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":43,"alternative-id":["7076"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07076-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"31 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was an Institutional Review Board exemption for the current study due to secondary data analysis. Data used in the preparation of this article was obtained from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the original study. Data used in the preparation of this article was obtained from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}